Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13667)
All Articles published online
|
Publishing Process of This Article
|
Nov 18, 2015 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol 2015; 7(26): 2648-2663 [PMID: 26609342 DOI: 10.4254/wjh.v7.i26.2648] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i26/2648.htm |
| Number | Citing Articles |
| 1 |
Luca Di Leo, Rolando Vegliante, Fabio Ciccarone, Illari Salvatori, Manuel Scimeca, Elena Bonanno, Andrea Sagnotta, Gian Luca Grazi, Katia Aquilano, Maria Rosa Ciriolo. Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53. Oncogene 2019; 38(11): 1860 doi: 10.1038/s41388-018-0545-0
|
| 2 |
Hsi-Wen Yeh, Szu-Shuo Lee, Chieh-Yu Chang, Chun-Mei Hu, Yuh-Shan Jou. Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis. Oncotarget 2017; 8(44): 77734 doi: 10.18632/oncotarget.20774
|
| 3 |
Jin‐Yu Sun, Xiao‐Yu Zhang, Yi‐Zhi Cao, Xiao Zhou, Jian Gu, Xiao‐Xin Mu. Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2020; 24(10): 5438 doi: 10.1111/jcmm.15258
|
| 4 |
Xincheng Liu, Huohui Ou, Leyang Xiang, Xianghong Li, Yu Huang, Dinghua Yang. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma. Oncotarget 2017; 8(6): 10510 doi: 10.18632/oncotarget.14446
|
| 5 |
Rumeysa ÖZYURT, Mete OZKURT, Abdullah KARADAĞ, Cemile MERAL, Nılufer ERKASAP. Ceranib-2 inhibits HIF1-α gene expression and induces apoptosis in HepG2 cells. Cukurova Medical Journal 2020; 45(4): 1318 doi: 10.17826/cumj.702236
|
| 6 |
Honghua Yan, Kyung Hee Jung, Juyoung Kim, Marufa Rumman, Myung Sook Oh, Soon-Sun Hong. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway. Biomedicine & Pharmacotherapy 2018; 98: 134 doi: 10.1016/j.biopha.2017.12.043
|
| 7 |
Jens Hemmingsson, Jonas Högberg, Johan Mölne, Johanna Svensson, Peter Gjertsson, Magnus Rizell, Olof Henrikson, Peter Bernhardt. Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities. Advances in Radiation Oncology 2018; 3(3): 439 doi: 10.1016/j.adro.2018.04.008
|
| 8 |
Zhijun Yu, Yinyin Li, Tao Han, Zhaozhe Liu. Demethylation of the HACE1 gene promoter inhibits the proliferation of human liver cancer cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10139
|
| 9 |
Arthur Cassio de Lima Luna, Fabio Luis Forti. Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation. Molecular and Cellular Biochemistry 2021; 476(9): 3393 doi: 10.1007/s11010-021-04167-5
|
| 10 |
Parisa Naeli, Mohammad Hossein Pourhanifeh, Mohammad Reza Karimzadeh, Zahra Shabaninejad, Ahmad Movahedpour, Hossein Tarrahimofrad, Hamid Reza Mirzaei, Hassan Hassani Bafrani, Amir Savardashtaki, Hamed Mirzaei, Michael R. Hamblin. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Critical Reviews in Oncology/Hematology 2020; 145: 102854 doi: 10.1016/j.critrevonc.2019.102854
|
| 11 |
|
| 12 |
Zeng-Fa Gao, Yong-Na Wu, Zhong-Tian Bai, Lei Zhang, Qi Zhou, Xun Li. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance. Oncology Reports 2016; 36(6): 3427 doi: 10.3892/or.2016.5205
|
| 13 |
Matthias Van Haele, Tania Roskams. Hepatic Progenitor Cells. Gastroenterology Clinics of North America 2017; 46(2): 409 doi: 10.1016/j.gtc.2017.01.011
|
| 14 |
Leila Valanejad, Nikolai Timchenko. Akt‐FoxO1 axis controls liver regeneration. Hepatology 2016; 63(5): 1424 doi: 10.1002/hep.28440
|
| 15 |
Na Ling, Xiaojun Zhou, Yubin Ji, Wenlan Li, Chenfeng Ji, Zheng Qi. Immuno-modulatory and cellular antioxidant activities of κ-selenocarrageenan in combination with Epirubicin in H22 hepatoma-bearing mice. Biomedicine & Pharmacotherapy 2017; 91: 132 doi: 10.1016/j.biopha.2017.04.064
|
| 16 |
Ping-Hsing Tsai, Mong-Lien Wang, Jen-Hsuan Chang, Aliaksandr A. Yarmishyn, Phan Nguyen Nhi Nguyen, Wei Chen, Yueh Chien, Teh-Ia Huo, Chung-Yuan Mou, Shih-Hwa Chiou. Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem Cells. ACS Applied Materials & Interfaces 2019; 11(22): 19808 doi: 10.1021/acsami.9b04474
|
| 17 |
Nischal Koirala, Dola Das, Ehsan Fayazzadeh, Sanghamitra Sen, Andrew McClain, Judit E. Puskas, Judith A. Drazba, Gordon McLennan. Folic acid conjugated polymeric drug delivery vehicle for targeted cancer detection in hepatocellular carcinoma. Journal of Biomedical Materials Research Part A 2019; 107(11): 2522 doi: 10.1002/jbm.a.36758
|
| 18 |
Firoz A. Dain Md Opo, Mohammed M. Rahman, Foysal Ahammad, Istiak Ahmed, Mohiuddin Ahmed Bhuiyan, Abdullah M. Asiri. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83626-x
|
| 19 |
Ana Isabel Oliveira, Cláudia Pinho, Filipa Quintela Vieira, Regina Silva, Agostinho Cruz. Taraxacum spp. in vitro and in vivo anticancer activity – A review. Journal of Herbal Medicine 2022; 36: 100612 doi: 10.1016/j.hermed.2022.100612
|
| 20 |
Hamidreza Khodajou-Masouleh, Masoud Mashhadi Akbar Boojar, Sarah Khavari-Nejad, Gilda Karimi. Induction of apoptosis by Oleracein A and Oleracein B in HepG2 cancerous cells is mediated by ceramide generation, caspase-9/caspase-3 pathway activation, and oxidative damage. Pharmacological Research - Modern Chinese Medicine 2022; 2: 100047 doi: 10.1016/j.prmcm.2022.100047
|
| 21 |
Dan Yue, Xun Sun. Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma. Cell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-0960-8
|
| 22 |
Young-Jun Jeon, Sanghee Kim, Ji Hee Kim, Ui Joung Youn, Sung-Suk Suh. The Comprehensive Roles of ATRANORIN, A Secondary Metabolite from the Antarctic Lichen Stereocaulon caespitosum, in HCC Tumorigenesis. Molecules 2019; 24(7): 1414 doi: 10.3390/molecules24071414
|
| 23 |
Ruchi Jain, Josh P. Frederick, Eric Y. Huang, Kristine E. Burke, David M. Mauger, Elizaveta A. Andrianova, Sam J. Farlow, Summar Siddiqui, Jeffrey Pimentel, Kahlin Cheung-Ong, Kristine M. McKinney, Caroline Köhrer, Melissa J. Moore, Tirtha Chakraborty. MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct. Nucleic Acid Therapeutics 2018; 28(5): 285 doi: 10.1089/nat.2018.0734
|
| 24 |
Changwen Bo, Na Li, Xiuli Li, Xianwei Liang, Yonghui An. Long noncoding RNA uc.338 promotes cell proliferation through association with BMI1 in hepatocellular carcinoma. Human Cell 2016; 29(4): 141 doi: 10.1007/s13577-016-0140-z
|
| 25 |
Raju Suresh Kumar, Dhaifallah M. Al-thamili, Khloud Ibrahim Al-Shemaimari, Faruq Mohammad, Mohamad Altaf, Rashid Ayub. Design, stereoselective synthesis and anticancer efficacy of a new class of functionalized pyrrolizidine heterocyclic hybrids. Journal of King Saud University - Science 2024; 36(1): 103009 doi: 10.1016/j.jksus.2023.103009
|
| 26 |
J Gowthami, N Gururaj, V Mahalakshmi, R Sathya, TR Sabarinath, DaffneyMano Doss. Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review. Journal of Oral and Maxillofacial Pathology 2020; 24(2): 293 doi: 10.4103/jomfp.JOMFP_348_19
|
| 27 |
Abu Bakar Hafeez Bhatti, Faisal Saud Dar, Anum Waheed, Kashif Shafique, Faisal Sultan, Najmul Hassan Shah. Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5942306
|
| 28 |
Sarah Scollon, Amanda Knoth Anglin, Martha Thomas, Joyce T. Turner, Kami Wolfe Schneider. A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes. Journal of Genetic Counseling 2017; 26(3): 387 doi: 10.1007/s10897-017-0077-8
|
| 29 |
Sabine Gerum, Alexandra D Jensen, Falk Roeder. Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review. World Journal of Gastrointestinal Oncology 2019; 11(5): 367-376 doi: 10.4251/wjgo.v11.i5.367
|
| 30 |
Wenqing Tang, Zhiying Zhao, Chen Wang, Tao Ye, Biwei Yang. Molecular design and optimization of hepatic cancer SLP76‐derived PLCγ1 SH3‐binding peptide with the systematic N‐substitution of peptide PXXP motif. Journal of Molecular Recognition 2019; 32(12) doi: 10.1002/jmr.2806
|
| 31 |
Brenda de Oliveira da Silva, Luciane Carla Alberici, Letícia Ferreira Ramos, Caio Mateus Silva, Marina Bonfogo da Silveira, Carlos R.P. Dechant, Scott L. Friedman, Kumiko Koibuchi Sakane, Letícia Rocha Gonçalves, Karen C.M. Moraes. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1–7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolism. The International Journal of Biochemistry & Cell Biology 2018; 98: 137 doi: 10.1016/j.biocel.2018.02.018
|
| 32 |
Bruno Aragão Rocha, Lorena Carneiro Ferreira, Luis Gustavo Rocha Vianna, Luma Gallacio Gomes Ferreira, Ana Claudia Martins Ciconelle, Alex Da Silva Noronha, João Martins Cortez Filho, Lucas Salume Lima Nogueira, Jean Michel Rocha Sampaio Leite, Maurício Ricardo Moreira da Silva Filho, Claudia da Costa Leite, Marcelo de Maria Felix, Marco Antônio Gutierrez, Cesar Higa Nomura, Giovanni Guido Cerri, Flair José Carrilho, Suzane Kioko Ono. Contrast phase recognition in liver computer tomography using deep learning. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24485-y
|
| 33 |
Pengcheng Hu, Dengfeng Cheng, Tao Huang, Anna B. Banizs, Jie Xiao, Guobing Liu, Quan Chen, Yuenan Wang, Jiang He, Hongcheng Shi. Evaluation of Novel 64Cu-Labeled Theranostic Gadolinium-Based Nanoprobes in HepG2 Tumor-Bearing Nude Mice. Nanoscale Research Letters 2017; 12(1) doi: 10.1186/s11671-017-2292-5
|
| 34 |
Carole Sourbier. Plasma HSP90α and liver cancer: a potential biomarker?. EBioMedicine 2017; 25: 7 doi: 10.1016/j.ebiom.2017.10.012
|
| 35 |
Javier A García-Vilas, Miguel Ángel Medina. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications. World Journal of Gastroenterology 2018; 24(33): 3695-3708 doi: 10.3748/wjg.v24.i33.3695
|
| 36 |
Guiliang Wang, Yan Liu, Shu-feng Zhou, Ping Qiu, Linfang Xu, Ping Wen, Jianbo Wen, Xianzhong Xiao. Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review. Hepatology International 2016; 10(3): 501 doi: 10.1007/s12072-015-9700-7
|
| 37 |
Qi Wang, Xiangyu Zhang, Hongze Liao, Ying Sun, Li Ding, Yanwei Teng, Wei‐Hong Zhu, Zhirong Zhang, Yourong Duan. Multifunctional Shell–Core Nanoparticles for Treatment of Multidrug Resistance Hepatocellular Carcinoma. Advanced Functional Materials 2018; 28(14) doi: 10.1002/adfm.201706124
|
| 38 |
Sukeshi Patel Arora, Gabor Liposits, Susan Caird, Richard F. Dunne, Gordon Taylor Moffat, David Okonji, Maria Grazia Rodriquenz, Divyanshu Dua, Efrat Dotan. Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology. Journal of Geriatric Oncology 2020; 11(4): 557 doi: 10.1016/j.jgo.2019.10.007
|
| 39 |
Yong Zhou, Wen-Yang Shi, Wei He, Zhao-Wen Yan, Man-Hua Liu, Jing Chen, Yun-Sheng Yang, Yin-Qi Wang, Guo-Qiang Chen, Ying Huang. FAM122A supports the growth of hepatocellular carcinoma cells and its deletion enhances Doxorubicin-induced cytotoxicity. Experimental Cell Research 2020; 387(1): 111714 doi: 10.1016/j.yexcr.2019.111714
|
| 40 |
Susan L Stewart, Sandy L Kwong, Christopher L Bowlus, Tung T Nguyen, Annette E Maxwell, Roshan Bastani, Eric W Chak, Moon S Chen Jr. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012. World Journal of Gastroenterology 2016; 22(38): 8584-8595 doi: 10.3748/wjg.v22.i38.8584
|
| 41 |
Zhouhua Hou, Jun Quan. Hepatitis B virus X protein increases microRNA-21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway. Molecular Medicine Reports 2017; 15(5): 3285 doi: 10.3892/mmr.2017.6363
|
| 42 |
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experience. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 67 doi: 10.16931/1995-5464.2020267-76
|
| 43 |
Pradeep Madhamanchi, Kishore Madhamanchi, Sujatha Peela, Panchareddy Madhava Rao, Pallaval Veera Bramhachari, Prakash Babu Panithi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 255 doi: 10.1016/B978-0-323-98807-0.00021-1
|
| 44 |
Hindrik Kruit, Kalloor Joseph Francis, Elina Rascevska, Srirang Manohar. Annular Fiber Probe for Interstitial Illumination in Photoacoustic Guidance of Radiofrequency Ablation. Sensors 2021; 21(13): 4458 doi: 10.3390/s21134458
|
| 45 |
Mohd. A. Siddiqui , Hefazat H. Siddiqui, Anuradha Mishra , Afreen Usmani . Evaluation of Cytotoxic Activity of Lavandula stoechas Aerial Parts Fractions against HepG2 Cell Lines. Current Bioactive Compounds 2020; 16(9): 1281 doi: 10.2174/1573407215666190916102325
|
| 46 |
Zhangang Xiao, Jing Shen, Lin Zhang, Mingxing Li, Wei Hu, Chihin Cho. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.7758
|
| 47 |
Marie-Hélène Wasmer, Philippe Krebs. The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment. Frontiers in Immunology 2017; 7 doi: 10.3389/fimmu.2016.00682
|
| 48 |
Xiaoxin Jin, Lifeng Cai, Changfa Wang, Xiaofeng Deng, Shengen Yi, Zhao Lei, Qiangsheng Xiao, Hongbo Xu, Hongwu Luo, Jichun Sun. CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3. Cell Death & Disease 2018; 9(3) doi: 10.1038/s41419-018-0350-2
|
| 49 |
Jaewoo Hong, Soohyun Kim, P. Charles Lin. Interleukin-33 and ST2 Signaling in Tumor Microenvironment. Journal of Interferon & Cytokine Research 2019; 39(1): 61 doi: 10.1089/jir.2018.0044
|
| 50 |
Chu Chen, Tao Lou. Hypoxia inducible factors in hepatocellular carcinoma. Oncotarget 2017; 8(28): 46691 doi: 10.18632/oncotarget.17358
|
| 51 |
Shima Ghavimi, Tehila Apfel, Hamed Azimi, Alana Persaud, Nikolaos T. Pyrsopoulos. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options. Journal of Clinical and Translational Hepatology 2020; 8(2): 168 doi: 10.14218/JCTH.2020.00001
|
| 52 |
Arya Mariam Roy, Renuka Iyer, Sayan Chakraborty. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability. Cell Reports Medicine 2023; 4(9): 101170 doi: 10.1016/j.xcrm.2023.101170
|
| 53 |
Junya Matsushita, Takehiro Suzuki, Kazuyuki Okamura, Gaku Ichihara, Keiko Nohara. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes. Environmental Health and Preventive Medicine 2020; 25(1) doi: 10.1186/s12199-020-00871-8
|
| 54 |
Tomoki Sempokuya, Kishan P Patel, Muaataz Azawi, Jihyun Ma, Linda L Wong. Increased morbidity and mortality of hepatocellular carcinoma patients in lower cost of living areas. World Journal of Clinical Cases 2021; 9(23): 6734-6746 doi: 10.12998/wjcc.v9.i23.6734
|
| 55 |
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseases. Advanced Drug Delivery Reviews 2019; : 72 doi: 10.1016/j.addr.2019.11.001
|
| 56 |
Vitoantonio Bevilacqua, Antonio Brunetti, Gianpaolo Francesco Trotta, Leonarda Carnimeo, Francescomaria Marino, Vito Alberotanza, Arnaldo Scardapane. Deep Learning and Neural Networks. 2020; : 353 doi: 10.4018/978-1-7998-0414-7.ch021
|
| 57 |
Matlola Bopape, Charlette Tiloke, Claudia Ntsapi.
Moringa oleifera
and Autophagy: Evidence from
In Vitro
Studies on Chaperone-Mediated Autophagy in HepG
2
Cancer Cells
. Nutrition and Cancer 2023; 75(10): 1822 doi: 10.1080/01635581.2023.2270215
|
| 58 |
Tingting Sun, Jinfeng Han, Shi Liu, Xin Wang, Zhi Yuan Wang, Zhigang Xie. Tailor-Made Semiconducting Polymers for Second Near-Infrared Photothermal Therapy of Orthotopic Liver Cancer. ACS Nano 2019; 13(6): 7345 doi: 10.1021/acsnano.9b03910
|
| 59 |
Yu-Cheng Liu, Daniel Stanley Tan, Jyh-Cheng Chen, Wen-Huang Cheng, Kai-Lung Hua. Segmenting Hepatic Lesions Using Residual Attention U-Net with an Adaptive Weighted Dice Loss. 2019 IEEE International Conference on Image Processing (ICIP) 2019; : 3322 doi: 10.1109/ICIP.2019.8803471
|
| 60 |
Anahid Amiri, Florian D. Hastert, Christian Dietz. Carcinomas with Occult Metastasis Potential: Diagnosis/Prognosis Accuracy Improvement by Means of Force Spectroscopy. Advanced Biosystems 2020; 4(7) doi: 10.1002/adbi.202000042
|
| 61 |
Payal Deepak, Rajinikanth Siddalingam, Praveen Kumar, Sneha Anand, Sunita Thakur, Balasubramaniam Jagdish, Shweta Jaiswal. Gene based nanocarrier delivery for the treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2020; 59: 101837 doi: 10.1016/j.jddst.2020.101837
|
| 62 |
Saimila Momin, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 253 doi: 10.1007/978-981-15-5471-1_15
|
| 63 |
Shivanand P. Gajare, Prakash A. Bansode, Pradnya V. Patil, Audumbar D. Patil, Dattaprasad M. Pore, Kailas D. Sonawane, Maruti J. Dhanavade, Vishwajeet M. Khot, Gajanan S. Rashinkar. Anticancer, Antibacterial and Hyperthermia Studies of a Caffeine‐Based N‐Heterocyclic Carbene Silver Complex Anchored on Magnetic Nanoparticles. ChemistrySelect 2021; 6(9): 1958 doi: 10.1002/slct.202004139
|
| 64 |
Pengcheng Hu, Zhequan Fu, Guobing Liu, Hui Tan, Jie Xiao, Hongcheng Shi, Dengfeng Cheng. Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma. Frontiers in Bioengineering and Biotechnology 2019; 7 doi: 10.3389/fbioe.2019.00368
|
| 65 |
Hua Ding, Zhi-Hua Ye, Dong-Yue Wen, Xiao-Liang Huang, Chu-Mei Zeng, Jie Mo, Yi-Qiang Jiang, Jian-Jun Li, Xiao-Yong Cai, Hong Yang, Gang Chen. Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significance. Molecular Medicine Reports 2017; 16(4): 5393 doi: 10.3892/mmr.2017.7275
|
| 66 |
Pooja Siniprasad, Bhagyalakshmi Nair, Vaisali Balasubramaniam, Prashanth Sadanandan, Puliyapally Krishnan Namboori, Lekshmi Reghu Nath. Evaluation of Kaempferol as AKT Dependent mTOR Regulator via Targeting FKBP-12 in Hepatocellular Carcinoma: An In silico Approach. Letters in Drug Design & Discovery 2020; 17(11): 1401 doi: 10.2174/1570180817999200623115703
|
| 67 |
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
|
| 68 |
Sherouk M. Tawfik, Maha R. A. Abdollah, Mohey M. Elmazar, Hassan A. N. El-Fawal, Anwar Abdelnaser. Effects of Metformin Combined With Antifolates on HepG2 Cell Metabolism and Cellular Proliferation. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.828988
|
| 69 |
Hsin-Yi Lee, Chi-Kuan Chen, Chun-Ming Ho, Szu-Shuo Lee, Chieh-Yu Chang, Kuan-Ju Chen, Yuh-Shan Jou. EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma. Oncotarget 2018; 9(17): 13193 doi: 10.18632/oncotarget.24149
|
| 70 |
Zhong-dong Wang, Fan-yong Qu, Yuan-yuan Chen, Zhang-shen Ran, Hai-yan Liu, Hai-dong Zhang. Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells. Journal of Zhejiang University-SCIENCE B 2017; 18(1): 27 doi: 10.1631/jzus.B1600205
|
| 71 |
Vitoantonio Bevilacqua, Antonio Brunetti, Gianpaolo Francesco Trotta, Leonarda Carnimeo, Francescomaria Marino, Vito Alberotanza, Arnaldo Scardapane. A Deep Learning Approach for Hepatocellular Carcinoma Grading. International Journal of Computer Vision and Image Processing 2017; 7(2): 1 doi: 10.4018/IJCVIP.2017040101
|
| 72 |
Yan Wang, Mengjing Sun, Jibin Liu, Ying Liu, Chunyi Jiang, Huijun Zhu, Wei Wang, Yao Wang. FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.11183
|
| 73 |
Sejal S. Shah, Tsung-Teh Wu, Michael S. Torbenson, Vishal S. Chandan. Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall. Human Pathology 2017; 64: 13 doi: 10.1016/j.humpath.2016.12.029
|
| 74 |
Ning Li, Yuting Jiang, Rosalie Plantefève, Francois Michaud, Zeynab Nosrati, Charles Tremblay, Katayoun Saatchi, Urs O. Häfeli, Samuel Kadoury, Gerald Moran, Florian Joly, Sylvain Martel, Gilles Soulez. Magnetic Resonance Navigation for Targeted Embolization in a Two-Level Bifurcation Phantom. Annals of Biomedical Engineering 2019; 47(12): 2402 doi: 10.1007/s10439-019-02317-x
|
| 75 |
Ahmed Mahmoud, Kellee Slater. Hepatocellular Carcinoma Misdiagnosed as a Liver Abscess – A Story of Misdiagnosis and Long-Term Malignant Disease Control. Cureus 2021; doi: 10.7759/cureus.12636
|
| 76 |
Yao Xiao, Guodong Liu, Xiwu Ouyang, Denggao Zai, Jixiang Zhou, Xiaoli Li, Qi Zhang, Jie Zhao. Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00111
|
| 77 |
Wei Meng, Tao Chen. Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review). Oncology Reports 2021; 46(3) doi: 10.3892/or.2021.8142
|
| 78 |
Weiyue Li, Xiang Xiao, Xiaodan Li, Yikai Xu, Lichao Ma, Liuji Guo, Chenggong Yan, Yuankui Wu. Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments. Contrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9169072
|
| 79 |
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Paprottka, Enrico N. De Toni, Falk Roeder. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease. Radiation Oncology 2018; 13(1) doi: 10.1186/s13014-018-1048-4
|
| 80 |
Emmeline Ha, Frederic Kim, Janice Blanchard, Hee-Soon Juon. Prevalence of Chronic Hepatitis B and C Infection in Mongolian Immigrants in the Washington, District of Columbia, Metropolitan Area, 2016–2017. Preventing Chronic Disease 2019; 16 doi: 10.5888/pcd16.180104
|
| 81 |
Yihao Li, Haoyu Gao, Eugenie Nepovimova, Qinghua Wu, Vojtech Adam, Kamil Kuca. Recombinant ferritins for multimodal nanomedicine. Journal of Enzyme Inhibition and Medicinal Chemistry 2023; 38(1) doi: 10.1080/14756366.2023.2219868
|
| 82 |
Gian Piero Guerrini, Domenico Pinelli, Elena Marini, Vittorio Corno, Michela Guizzetti, Marco Zambelli, Alessandro Aluffi, Lisa Lincini, Stefano Fagiuoli, Alessandro Lucianetti, Michele Colledan. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation. Progress in Transplantation 2018; 28(1): 63 doi: 10.1177/1526924817746686
|
| 83 |
Tawatchai Apidechkul. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3747-3
|
| 84 |
Ishaan Vohra, Bashar Attar, Vatsala Katiyar, Pedro Palacios, Tejinder Randhawa, Muhammad Arslan Baig, Estefania Flores, Yuchen Wang, Hemant Mutneja, Sachit Sharma, Prashanth Lingamneni, Muhammad Zain Farooq, Naveen Bhaskaran, Seema Gandhi, Gijo Vettiankal, Melchor Demetria. Evaluation of Ferritin and Transferrin Ratio as a Prognostic Marker for Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2021; 52(1): 201 doi: 10.1007/s12029-020-00373-4
|
| 85 |
Roland Böttger, Griffin Pauli, Po-Han Chao, Nojoud AL Fayez, Lukas Hohenwarter, Shyh-Dar Li. Lipid-based nanoparticle technologies for liver targeting. Advanced Drug Delivery Reviews 2020; : 79 doi: 10.1016/j.addr.2020.06.017
|
| 86 |
Aly O. Aboelfotoh, Enas M. Foda, Ahmed M. Elghandour, Nahla M. Teama, Reham A. Abouzein, Ghada A. Mohamed. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosis. Arab Journal of Gastroenterology 2020; 21(2): 80 doi: 10.1016/j.ajg.2020.04.017
|
| 87 |
Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02104-8
|
| 88 |
Nikolaus Berndt, Antje Egners, Guido Mastrobuoni, Olga Vvedenskaya, Athanassios Fragoulis, Aurélien Dugourd, Sascha Bulik, Matthias Pietzke, Chris Bielow, Rob van Gassel, Steven W. Olde Damink, Merve Erdem, Julio Saez-Rodriguez, Hermann-Georg Holzhütter, Stefan Kempa, Thorsten Cramer. Kinetic modelling of quantitative proteome data predicts metabolic reprogramming of liver cancer. British Journal of Cancer 2020; 122(2): 233 doi: 10.1038/s41416-019-0659-3
|
| 89 |
Ghada H. Mansour, Mohammed A. El-Magd, Dalia H. Mahfouz, Ismail A. Abdelhamid, Magda F. Mohamed, Nada S. Ibrahim, Abdel Hady A. Abdel Wahab, Emad M. Elzayat. Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells. Bioorganic Chemistry 2021; 116: 105329 doi: 10.1016/j.bioorg.2021.105329
|
| 90 |
Wei Dong, Zhi-hui Dai, Fu-chen Liu, Xing-gang Guo, Chun-mei Ge, Jin Ding, Hui Liu, Fu Yang. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production. EBioMedicine 2019; 45: 155 doi: 10.1016/j.ebiom.2019.06.030
|
| 91 |
Asmaa Abdel Nabi, Shimaa Attia Atta, Eman El-Ahwany, Emad Elzayat, Hanan Saleh. Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma. Molecular Biology Reports 2021; 48(7): 5549 doi: 10.1007/s11033-021-06571-y
|
| 92 |
Marco Di Paola, Alessandra Quarta, Francesco Conversano, Enzo Antonio Sbenaglia, Simona Bettini, Ludovico Valli, Giuseppe Gigli, Sergio Casciaro. Human Hepatocarcinoma Cell Targeting by Glypican-3 Ligand Peptide Functionalized Silica Nanoparticles: Implications for Ultrasound Molecular Imaging. Langmuir 2017; 33(18): 4490 doi: 10.1021/acs.langmuir.7b00327
|
| 93 |
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Marius Paprottka, Enrico N De Toni, Falk Roeder. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting. Strahlentherapie und Onkologie 2020; 196(4): 334 doi: 10.1007/s00066-019-01540-8
|
| 94 |
Lipeng Qiu, Qi Tang, Guohui Li, Keping Chen. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma. Life Sciences 2017; 191: 273 doi: 10.1016/j.lfs.2017.10.007
|
| 95 |
Miao-Mei Yu, Yue-Hua Feng, Lu Zheng, Jun Zhang, Guang-Hua Luo. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells. World Journal of Gastroenterology 2019; 25(10): 1210-1223 doi: 10.3748/wjg.v25.i10.1210
|
| 96 |
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
|
| 97 |
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opinion on Drug Delivery 2021; 18(4): 489 doi: 10.1080/17425247.2021.1854223
|
| 98 |
Yulia A. Nevzorova, Johannes Grossmann, Christian Trautwein. Anti-tumorigenic and anti-angiogenic effects of natural conifer Abies sibirica terpenoids in vivo and in vitro. Biomedicine & Pharmacotherapy 2017; 89: 386 doi: 10.1016/j.biopha.2017.02.035
|
| 99 |
Anil Kumar Chauhan, Monika Bhardwaj, Pankaj Kumar Chaturvedi. Molecular Diagnostics in Cancer Patients. 2019; : 293 doi: 10.1007/978-981-13-5877-7_17
|
| 100 |
Yunbin Zhang, Jiang Xu, Ning Zhang, Ming Chen, Hua Wang, Di Zhu. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies. Cancer Letters 2019; 458: 123 doi: 10.1016/j.canlet.2019.05.017
|
| 101 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 125 doi: 10.1007/978-3-031-10839-6_5
|
| 102 |
Hyosun Tak, Hoin Kang, Eunbyul Ji, Youlim Hong, Wook Kim, Eun Kyung Lee. Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2018; 497(4): 1117 doi: 10.1016/j.bbrc.2018.02.189
|
| 103 |
Heba H. Sokkar, Ahmed S. Abo Dena, Noha Ahmed Mahana, Abeer Badr. Artichoke extracts in cancer therapy: do the extraction conditions affect the anticancer activity?. Future Journal of Pharmaceutical Sciences 2020; 6(1) doi: 10.1186/s43094-020-00088-0
|
| 104 |
Maria Cristina Bonferoni, Elisabetta Gavini, Giovanna Rassu, Marcello Maestri, Paolo Giunchedi. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials 2020; 10(5): 870 doi: 10.3390/nano10050870
|
| 105 |
Daoshan Zheng, Cecilia Williams, Jeremy A. Vold, Justin H. Nguyen, Denise M. Harnois, Sanjay P. Bagaria, Sarah A. McLaughlin, Zhaoyu Li. Regulation of sex hormone receptors in sexual dimorphism of human cancers. Cancer Letters 2018; 438: 24 doi: 10.1016/j.canlet.2018.09.001
|
| 106 |
Dong Ik Cha, Kyung Mi Jang, Seong Hyun Kim, Tae Wook Kang, Kyoung Doo Song. Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging. European Radiology 2017; 27(10): 4394 doi: 10.1007/s00330-017-4804-1
|
| 107 |
Joseph M. Obeid, Paul R. Kunk, Victor M. Zaydfudim, Timothy N. Bullock, Craig L. Slingluff, Osama E. Rahma. Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?. Cancer Immunology, Immunotherapy 2018; 67(2): 161 doi: 10.1007/s00262-017-2082-z
|
| 108 |
Ankit Banik, Karishma Shaw, Aejaz Ahmad Dar, Sujatha Peela, Pavan Kumar Kancharla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 59 doi: 10.1016/B978-0-323-98807-0.00022-3
|
| 109 |
Chih-Tien Chen, Hsiang-Lin Lee, Hui-Ling Chiou, Chia-Hsuan Chou, Po-Hui Wang, Shun-Fa Yang, Ying-Erh Chou, Pavel Strnad. Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development. PLOS ONE 2018; 13(6): e0198967 doi: 10.1371/journal.pone.0198967
|
| 110 |
Dongqiang Song, Beili Xu, Dongmin Shi, Shuyu Li, Yu Cai. S100A6 promotes proliferation and migration of HepG2 cells via increased
ubiquitin-dependent degradation of p53. Open Medicine 2020; 15(1): 317 doi: 10.1515/med-2020-0101
|
| 111 |
Muhammad Ma’ruf, Lalu Muhammad Irham, Wirawan Adikusuma, Made Ary Sarasmita, Sabiah Khairi, Barkah Djaka Purwanto, Rockie Chong, Maulida Mazaya, Lalu Muhammad Harmain Siswanto. A genomic and bioinformatic-based approach to identify genetic variants for liver cancer across multiple continents. Genomics & Informatics 2023; 21(4): e48 doi: 10.5808/gi.23067
|
| 112 |
Sayali Pravin Metkar, Gasper Fernandes, Prerana D. Navti, Ajinkya N. Nikam, Ritu Kudarha, Namdev Dhas, Raviraja N Seetharam, Krishnan Venkata Santhosh, Bola Sadashiva Satish Rao, Srinivas Mutalik. Nanoparticle drug delivery systems in hepatocellular carcinoma: A focus on targeting strategies and therapeutic applications. OpenNano 2023; 12: 100159 doi: 10.1016/j.onano.2023.100159
|
| 113 |
Sriragavi Ravi, N. Nalini. THE CHEMOTHERAPEUTIC ROLE OF p-MCA IN AVERTING NDEA INDUCED HEPATIC CARCINOGENESIS IN EXPERIMENTAL WISTAR RATS. INDIAN JOURNAL OF APPLIED RESEARCH 2021; : 53 doi: 10.36106/ijar/4211815
|
| 114 |
Hany A. Omar, Dana M. Zaher, Vunnam Srinivasulu, Fatema Hersi, Hamadeh Tarazi, Taleb H. Al-Tel. Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma. European Journal of Medicinal Chemistry 2017; 139: 804 doi: 10.1016/j.ejmech.2017.08.054
|
| 115 |
Kuo-Shyang Jeng, Chi-Juei Jeng, Wen-Juei Jeng, Chiung-Fang Chang, I-Shyan Sheen. Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma. Oncology Letters 2017; 14(2): 1905 doi: 10.3892/ol.2017.6396
|
| 116 |
Brittany Dewdney, Alexandra Roberts, Liang Qiao, Jacob George, Lionel Hebbard. A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma. Biomolecules 2020; 10(4): 496 doi: 10.3390/biom10040496
|
| 117 |
Ulfa Kholili, Alvin Hartanto Kurniawan, Choirina Winda, Ummi Maimunah, Poernomo Budi Setiawan. The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma. Research Journal of Pharmacy and Technology 2023; : 377 doi: 10.52711/0974-360X.2023.00065
|
| 118 |
Xiukun Fei, Peipei Zhang, Yu Pan, Yuanyuan Liu. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Yonsei Medical Journal 2020; 61(6): 460 doi: 10.3349/ymj.2020.61.6.460
|
| 119 |
Lanxia Liu, Hai Wang, Qi Liu, Mingli Duan, Xia Dong, Dunwan Zhu, Yingjun Zhu, Xigang Leng. Biodistribution of TAT‐LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts. Journal of Biomedical Materials Research Part A 2016; 104(10): 2394 doi: 10.1002/jbm.a.35775
|
| 120 |
Shubhranil Kundu, Gorthala Guruprasad, Ruma Ghosh. Room Temperature H2S Sensing by rGO-MoS2 Composite. IEEE Sensors Letters 2024; 8(4): 1 doi: 10.1109/LSENS.2024.3373237
|
| 121 |
Da Xu, Jessica Qiuhua Sheng, Paul Jen-Hwa Hu, Ting Shuo Huang, Wei-Chen Lee. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variables. Journal of Biomedical Informatics 2019; 96: 103237 doi: 10.1016/j.jbi.2019.103237
|
| 122 |
Divya R, Radha P. An Optimized HCC Recurrence Prediction Using APO Algorithm Multiple Time Series Clinical Liver Cancer Dataset. Journal of Medical Systems 2019; 43(7) doi: 10.1007/s10916-019-1265-x
|
| 123 |
Zaki A. Sherif, Seyed Mehdi Nouraie, Edward Lee, Farshad Aduli, Hassan Brim, Hassan Ashktorab. Trends in the Incidence of Hepatocellular Carcinoma in Washington DC: A Single Institutional Cohort Study (1959–2013). Journal of the National Medical Association 2021; 113(4): 396 doi: 10.1016/j.jnma.2021.02.001
|
| 124 |
Margherita Maioli, Valentina Basoli, Paola Carta, Davide Fabbri, Maria Antonietta Dettori, Sara Cruciani, Pier Andrea Serra, Giovanna Delogu, Andrea Motta. Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells. PLOS ONE 2018; 13(2): e0192178 doi: 10.1371/journal.pone.0192178
|
| 125 |
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. International Journal of Molecular Sciences 2022; 23(18): 10862 doi: 10.3390/ijms231810862
|
| 126 |
F.A. Dain Md Opo, Mohammed Moulay, Ghadeer I. Alrefaei, Nouf H. Alsubhi, Saleh Alkarim, Mohammed M. Rahman. Effect of Co-culturing both placenta-derived mesenchymal stem cells and their condition medium in the cancer cell (HepG2) migration, damage through apoptosis and cell cycle arrest. Saudi Journal of Biological Sciences 2023; 30(2): 103519 doi: 10.1016/j.sjbs.2022.103519
|
| 127 |
Rafiqatul Khairi, Zuherman Rustam, Suarsih Utama. Possibilistics C-Means (PCM) Algorithm for the Hepatocellular Carcinoma (HCC) Classification. IOP Conference Series: Materials Science and Engineering 2019; 546(5): 052038 doi: 10.1088/1757-899X/546/5/052038
|
| 128 |
Angel Juarez-Flores, Marco José. Multivariate Entropy Characterizes the Gene Expression and Protein-Protein Networks in Four Types of Cancer. Entropy 2018; 20(3): 154 doi: 10.3390/e20030154
|
| 129 |
Hsin-An Chen, Chi-Cheng Li, Yu-Jung Lin, Tso-Fu Wang, Ming-Cheng Chen, Yen-Hao Su, Yu-Lan Yeh, V. Vijaya Padma, Po-Hsiang Liao, Chih-Yang Huang. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells. Aging 2021; 13(8): 12046 doi: 10.18632/aging.202908
|
| 130 |
Xiaofeng Hang, Zhiqin Wu, Kaijian Chu, Guanzhen Yu, Haoran Peng, Haiguang Xin, Xiaohui Miao, Junxue Wang, Wensheng Xu. Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patients. Tumor Biology 2016; 37(11): 15079 doi: 10.1007/s13277-016-5302-9
|
| 131 |
Winston Stauffer, Michael Bobardt, Daren Ure, Robert Foster, Philippe Gallay. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity. Viruses 2023; 15(10): 2099 doi: 10.3390/v15102099
|
| 132 |
Tracy Huang, Senlin Xu, Rucha Deo, An Ma, Hongzhi Li, Ke Ma, Xiaoxian Gan. Targeting the Ca2+/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cells. Biochemical and Biophysical Research Communications 2019; 508(4): 1227 doi: 10.1016/j.bbrc.2018.12.012
|
| 133 |
Daniel Hughes, Aron Hughes, Bilal Al-Sarireh. Hepatocellular carcinoma’s 100 most influential manuscripts: A bibliometric analysis. International Journal of Hepatobiliary and Pancreatic Diseases 2019; 9(2): 1 doi: 10.5348/100083Z04DH2019OA
|
| 134 |
Haijun Wang, Maria Carmenza Mejia, Sandra J. Gonzalez, Roger J. Zoorob, Weiwen Chai, Xianglin L. Du. Cancer incidence and survival trends among infants in the United States from 1975 to 2014. Pediatric Blood & Cancer 2021; 68(4) doi: 10.1002/pbc.28917
|
| 135 |
David F. Pinal-García, Carlos M. Nuño-Guzmán, Audrey Gómez-Abarca, Jorge L. Corona, Ismael Espejo. Spontaneous Rupture of Hepatocellular Carcinoma in a Young Patient with Fatal Outcome. Case Reports in Gastroenterology 2018; 12(1): 19 doi: 10.1159/000486193
|
| 136 |
Jean-Pierre Gillet, Jesper B. Andersen, James P. Madigan, Sudhir Varma, Rachel K. Bagni, Katie Powell, William E. Burgan, Chung-Pu Wu, Anna Maria Calcagno, Suresh V. Ambudkar, Snorri S. Thorgeirsson, Michael M. Gottesman. A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy. Molecular Pharmacology 2016; 89(2): 263 doi: 10.1124/mol.115.101360
|
| 137 |
Shalini Shukla, Shalu Singh, Rahul Shukla. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy. 2024; : 213 doi: 10.1016/B978-0-323-95303-0.00003-4
|
| 138 |
Ghulam Mustafa, Shumaila Younas, Hafiza Salaha Mahrosh, Mohammed Fahad Albeshr, Eijaz Ahmed Bhat. Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9. Molecules 2023; 28(8): 3583 doi: 10.3390/molecules28083583
|